Advances in Kidney Transplantation: 2nd Edition

Dear Colleagues,

The field of renal transplantation continues its transformation toward precision medicine, propelled by rapid advancements in our understanding of graft rejection, post-transplant complications, and the integration of innovative technologies such as artificial intelligence and nanotechnology.

Building on the foundation established in our previous volume, recent research has further refined the clinical application of biomarkers for graft monitoring, enabling earlier detection of rejection, subclinical inflammation, and new risk stratification strategies for transplant recipients. These biomarkers are increasingly used not only as diagnostic tools but also as therapeutic targets, contributing to improved post-transplant outcomes and personalized care.

The clinical integration of artificial intelligence and big data analytics is revolutionizing renal transplantation by enhancing the prediction of graft survival, optimizing donor–recipient matching, and personalizing immunosuppressive therapies. At the same time, advances in nanotechnology are opening new avenues for organ preservation, targeted drug delivery, and immune modulation, further raising the standards of transplant medicine.

All these efforts continue to advance the clinician’s approach to diagnosis, treatment, and prognosis prediction and offer new perspectives for long-term outcome improvement in renal transplantation. The aim of this second Special Issue volume is to showcase the latest scientific achievements in diagnosis, treatment, and prognosis innovation, emphasizing emerging technologies and translational research that are shaping the future of renal transplantation.

Dr. Pedro Ruiz-Esteban
Prof. Dr. Domingo Hernández
Dr. Veronica López
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.